TLR2 and cancer: Extract of larix leptolepis (ELL), which potentially activates TLR2 and TLR4 signaling, activates bone marrow-derived dendritic cells (BMDCs) to induce tumor-specific cytotoxic T lymphocytes (CTLs) against cancer [54].